124 related articles for article (PubMed ID: 19903463)
1. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.
Florou D; Papadopoulos IN; Scorilas A
Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463
[TBL] [Abstract][Full Text] [Related]
2. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
3. BCL2L12: a promising molecular prognostic biomarker in breast cancer.
Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A
Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Thomadaki H; Talieri M; Scorilas A
Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
[TBL] [Abstract][Full Text] [Related]
6. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
Floros KV; Talieri M; Scorilas A
Biol Chem; 2006 Dec; 387(12):1629-33. PubMed ID: 17132110
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
9. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Thomadaki H; Floros KV; Scorilas A
Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
[TBL] [Abstract][Full Text] [Related]
10. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
Thomadaki H; Talieri M; Scorilas A
Biol Chem; 2006 Aug; 387(8):1081-6. PubMed ID: 16895478
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A
Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012
[TBL] [Abstract][Full Text] [Related]
14. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A
Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250
[TBL] [Abstract][Full Text] [Related]
15. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
[TBL] [Abstract][Full Text] [Related]
16. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of bcl-2 expression in gastric cancer.
Müller W; Schneiders A; Hommel G; Gabbert HE
Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
[TBL] [Abstract][Full Text] [Related]
18. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Korbakis D; Scorilas A
Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053
[TBL] [Abstract][Full Text] [Related]
19. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
20. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A
Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]